Theralase Releases Q222 Interim Financial Statements
TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) — Theralase
Source: financialpost.com
Dynamic Compound Inactivation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dynamic Compound Inactivation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dynamic Compound Inactivation Today - Breaking & Trending Today
Theralase Releases Q122 Interim Financial Statements
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Theralase Releases Q122 Interim Financial Statements
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) — Theralase ® Technologies Inc. (“ Theralase ” or the “ Company ”) ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage…
Source: financialpost.com
Theralase Releases Q12021 Interim Financial Statements
TORONTO, May 28, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage…
Source: financialpost.com
Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine ® Technologies Inc. (" TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses, announced today that it has executed a Collaborative Research Agreement (" CRA") with the National Microbiology Laboratory, Public Health Agency of Canada ("...
Source: finanznachrichten.de